Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07808788 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

A Research Study Looking Into How a Single Dose of the Medicine NNC0537-1482 Moves Through the Body of Participants With Normal or Reduced Kidney Function

Name: A Research Study Looking Into How a Single Dose of the Medicine NNC0537-1482 Moves Through the Body of Participants With Normal or Reduced Kidney Function — clinical trial record (NCT07808788)
Creator: DataLookout
License: https://creativecommons.org/licenses/by/4.0/

StatusNot Yet Recruiting

PhasePhase 1

SponsorNovo Nordisk A/S

Started2026-09-04

View on ClinicalTrials.gov ↗

The purpose of the study to find out how the study medicine NNC0537-1482 moves through the body in people living with reduced kidney function compared to people with normal kidney function. All participants will get a single dose of the new medicine. The data for how much medicine is in the blood over time and compare levels between people with reduced and normal kidney function.

Trial Details

NCT Number	NCT07808788
Lead Sponsor	Novo Nordisk A/S
Conditions	Chronic Kidney Disease
Enrollment	54 participants
Start Date	2026-09-04
Primary Completion	2027-07-06 (estimated)
Study Completion	2027-07-06 (estimated)
Updated on ClinicalTrials.gov	2026-09-09